XML 42 R6.htm IDEA: XBRL DOCUMENT v2.4.0.8
Condensed Consolidated Statement of Cash Flows (USD $)
In Millions, unless otherwise specified
6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Net Income (Loss) Attributable to Parent $ 171.7 $ 200.2
Cash flows - operating activities:    
Net income   200.2
Depreciation and amortization 66.3 76.3
Net gains on investments (85.7) (161.2)
Amortization of share based compensation 10.4 14.8
Equity in earnings of unconsolidated affiliates (15.1) (6.7)
Dividends from unconsolidated affiliates 129.1 0.9
Deferred income taxes (2.5) (4.5)
Changes in accounts receivable 27.6 (0.3)
Changes in other assets (12.7) (35.8)
Changes in accounts payable and accrued liabilities (7.2) (14.0)
Changes in income taxes payable (15.5) 81.5
Changes in deferred revenues and gains (0.9) (21.6)
Changes in accrued compensation and benefits (22.4) (17.5)
Other, net 0.5 (2.4)
Total adjustments to net income 71.9 (90.5)
Net 243.6 109.7
Cash flows - investing activities:    
Capital expenditures (51.8) (50.4)
Investments in securities (53.9) (142.9)
Proceeds from sales/maturities of investments 190.7 319.0
Net (increase) decrease in restricted cash and cash equivalents held to satisfy client funds obligations 52.8 (6.1)
Other, net (13.2) 6.3
Net 124.6 125.9
Cash flows - financing activities:    
Proceeds from issuance of common stock 17.2 43.5
Principal payments on debt (22.7) (10.5)
Repurchases of senior convertible debentures (39.2)   
Net payments on revolving credit facilities (24.1) (164.6)
Net proceeds from accounts receivable securitization program 15.0  
Payment of debt issuance costs (0.2) (0.2)
Net increase (decrease) in client funds obligations (62.8) 8.6
Common stock repurchased (137.0) (27.9)
Payment for acquisition of non-controlling interest    (17.7)
Payment of cash dividends (26.4) (17.9)
Excess tax benefits from share based compensation 1.6 3.4
Net (278.6) (183.3)
Net increase in cash and cash equivalents 89.6 52.3
Cash and cash equivalents, beginning of period 88.3 40.9
Cash and cash equivalents, end of period $ 177.9 $ 93.2